1E Therapeutics

1E Therapeutics1E Therapeutics
1E Therapeutics

1E Therapeutics

Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform.

Website
DR 202020Active49
Rate
Advertise here

About

1E Therapeutics is a drug development company creating a novel class of programmable oligonucleotide therapeutics. Their patented platform autonomously and precisely silences disease-causing RNAs to treat intractable diseases, including genetically driven, infectious, and chronic conditions. This approach aims to deliver safer and more targeted therapies for a wide array of indications.
Frequently asked

What does 1E Therapeutics do?

1E Therapeutics is a drug development company creating a novel class of programmable oligonucleotide therapeutics. Their patented platform autonomously and precisely silences disease-causing RNAs to treat intractable diseases, including genetically driven, infectious, and chronic conditions. This approach aims to deliver safer and more targeted therapies for a wide array of indications.

What is 1E Therapeutics's valuation?

StartupHub estimates 1E Therapeutics's effective valuation at $475.2M (range $300.0M to $720.0M, 10% confidence), based on comparable companies in the sector.

How much funding has 1E Therapeutics raised?

1E Therapeutics has raised a total of $120M in funding. The most recent round on record is Seed.

When was 1E Therapeutics founded?

1E Therapeutics was founded in 2020.

What industry does 1E Therapeutics operate in?

1E Therapeutics operates in Drug Development, Life Sciences, Therapeutics, RNA-Targeting, Biotech, Drug Discovery.

How many employees does 1E Therapeutics have?

1E Therapeutics has approximately 49 people on record.

HEADCOUNT
49
DOMAIN RATING
20
Comments

No comments yet. Be the first to share your take.